Jeffrey T. L. Smith, EVP & Chief Medical Officer at Zymeworks Inc. (ZYME), sold 22,220 shares at $14.92 ($332K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Open-market sale of $332k ZYME by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.92 | 11,110 | $166K | 50.0% |
| 2 | $14.92 | 11,110 | $166K | 50.0% |
| Total | $14.92 avg | 22,220 | $332K | 100% |
| Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |
| ALDR | SELL | 2018-11-05 | $135K | — | Filing → |